Top ▲
Target id: 1537
Nomenclature: serine/threonine kinase 32A
Abbreviated Name: YANK1
Family: YANK family
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 396 | 5q32 | STK32A | serine/threonine kinase 32A | |
Mouse | - | 398 | 18 B3 | Stk32a | serine/threonine kinase 32A | |
Rat | - | 397 | 18p11 | Stk32a | serine/threonine kinase 32A |
Database Links | |
Alphafold | Q8WU08 (Hs), Q8BGW6 (Mm) |
BRENDA | 2.7.11.1 |
ChEMBL Target | CHEMBL6150 (Hs) |
Ensembl Gene | ENSG00000169302 (Hs), ENSMUSG00000039954 (Mm), ENSRNOG00000027066 (Rn) |
Entrez Gene | 202374 (Hs), 269019 (Mm), 364858 (Rn) |
Human Protein Atlas | ENSG00000169302 (Hs) |
KEGG Enzyme | 2.7.11.1 |
KEGG Gene | hsa:202374 (Hs), mmu:269019 (Mm), rno:364858 (Rn) |
Pharos | Q8WU08 (Hs) |
RefSeq Nucleotide | NM_001112724 (Hs), NM_178749 (Mm), NM_001191894 (Rn) |
RefSeq Protein | NP_001106195 (Hs), NP_848864 (Mm), NP_001178823 (Rn) |
UniProtKB | Q8WU08 (Hs), Q8BGW6 (Mm) |
Wikipedia | STK32A (Hs) |
Selected 3D Structures | |||||||||||
|
Enzyme Reaction | ||||
|
DiscoveRx KINOMEscan® screen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform. http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan Reference: 1-2 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target used in screen: YANK1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displaying the top 10 most potent ligands View all ligands in screen » |
1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]
2. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]
YANK family: serine/threonine kinase 32A. Last modified on 18/08/2014. Accessed on 15/10/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetomalariapharmacology.org/GRAC/ObjectDisplayForward?objectId=1537.